Plus   Neg

Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

Vertex Pharmaceuticals Inc. (VRTX) revealed earnings for its first quarter that advanced from the same period last year.

The company's earnings totaled $269 million, or $1.03 per share. This compares with $210 million, or $0.81 per share, in last year's first quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $296 million or $1.14 per share for the period.

Analysts had expected the company to earn $0.97 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 34.3% to $857 million from $638 million last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q1): $296 Mln. vs. $196 Mln. last year.
-EPS (Q1): $1.14 vs. $0.76 last year.
-Analysts Estimate: $0.97
-Revenue (Q1): $857 Mln vs. $638 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT